<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">sechenov</journal-id><journal-title-group><journal-title xml:lang="en">Sechenov Medical Journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Сеченовский вестник</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2218-7332</issn><issn pub-type="epub">2658-3348</issn><publisher><publisher-name>Сеченовский Университет</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">sechenov-810</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACEUTICAL CHEMISTRY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАЦЕВТИЧЕСКАЯ ХИМИЯ</subject></subj-group></article-categories><title-group><article-title>THE DEVELOPMENT AND VALIDATION OF METHODS FOR QUANTITATIVE DETERMINATION OF THIAMINE IN BLOOD PLASMA BY MEANS OF LC-MS METHOD PROVIDING STUDIES OF BIOEQUIVALENCE</article-title><trans-title-group xml:lang="ru"><trans-title>РАЗРАБОТКА И ВАЛИДАЦИЯ МЕТОДИКИ КОЛИЧЕСТВЕННОГО ОПРЕДЕЛЕНИЯ ТИАМИНА В ПЛАЗМЕ КРОВИ МЕТОДОМ LC-MS С ЦЕЛЬЮ ПРОВЕДЕНИЯ ИССЛЕДОВАНИЯ БИОЭКВИВАЛЕНТНОСТИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Таширова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tashirova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>О.А. Таширова, к.фарм.н., научный сотрудник</p></bio><bio xml:lang="en"><p>O.A. Tashirova, PhD, researcher</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>В.В. Смирнов, к.фарм.н., старший преподаватель кафедры фармацевтической и токсикологической химии</p></bio><bio xml:lang="en"><p>V.V. Smirnov, PhD, senior lecturer of the chair of pharmaceutical and toxicological chemistry</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Власов</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Vlasov</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>А.М. Власов, к.фарм.н., доцент кафедры фармацевтической и токсикологической химии</p></bio><bio xml:lang="en"><p>A.M. Vlasov, PhD, associate prof. of the chair of pharmaceutical and toxicological chemistry</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хаитов</surname><given-names>М. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Haitov</surname><given-names>M. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>М.Р. Хаитов, к.фарм.н., научный сотрудник</p></bio><bio xml:lang="en"><p>M.R. Haitov, PhD, researcher</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Раменская</surname><given-names>Г. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ramenskaya</surname><given-names>G. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галина Владиславовна Раменская, д.фарм.н., профессор, заведующая кафедрой фармацевтической и токсикологической химии, директор НИИ фармации8 (495) 691–13–92</p><p>119019, г. Москва, ул. Никитский бульвар, д. 13</p></bio><bio xml:lang="en"><p>G.V. Ramenskaya, Doctor of pharmacy, prof., head of the chair of pharmaceutical and toxicological chemistry, director of the Research institute of pharmacy</p></bio><email xlink:type="simple">ramenskaia@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт иммунологии ФМБА РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of immunology of FMBA of RF</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Первый МГМУ им. И.М. Сеченова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>First MSMU named after I.M. Sechenov</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>30</day><month>09</month><year>2012</year></pub-date><volume>0</volume><issue>3</issue><fpage>50</fpage><lpage>54</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Tashirova O.A., Smirnov V.V., Vlasov A.M., Haitov M.R., Ramenskaya G.V., 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="ru">Таширова О.А., Смирнов В.В., Власов А.М., Хаитов М.Р., Раменская Г.В.</copyright-holder><copyright-holder xml:lang="en">Tashirova O.A., Smirnov V.V., Vlasov A.M., Haitov M.R., Ramenskaya G.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sechenovmedj.com/jour/article/view/810">https://www.sechenovmedj.com/jour/article/view/810</self-uri><abstract><p>The methods for quantitative determination of thiamine in blood plasma by means of LC-MS method providing studies of bioequivalence are developed in this paper.</p></abstract><trans-abstract xml:lang="ru"><p>В статье разрабатывается методика количественного определения тиамина в плазме крови методом LC-MS с целью проведения исследования биоэквивалентности.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Плазма крови</kwd><kwd>тиамин</kwd><kwd>исследование биоэквивалентности</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Blood plasma</kwd><kwd>Thiamine</kwd><kwd>investigation of bioequivalence</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Singleton C.K., Martin P.R. Molecular mechanisms of thiamine utilization // Curr. Mol. Med. — 2001. — Vol. 1. — № 2. — P. 197–207.</mixed-citation><mixed-citation xml:lang="en">Singleton C.K., Martin P.R. Molecular mechanisms of thiamine utilization // Curr. Mol. Med. — 2001. — Vol. 1. — № 2. — P. 197–207.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Спиричев В.Б. Витамины, витаминоподобные и минеральные вещества. Справочник для провизоров и фармацевтов. — М., 2005. — 239 с.</mixed-citation><mixed-citation xml:lang="en">Спиричев В.Б. Витамины, витаминоподобные и минеральные вещества. Справочник для провизоров и фармацевтов. — М., 2005. — 239 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Конь И.Я., Тоболева М.А., Димитриева С.А. Дефицит витаминов у детей: основные причины, формы и пути профилактики у детей раннего и дошкольного возраста // Вопр. современной педиатрии. — 2002. — Т. 1. — № 2. — С. 62–66.</mixed-citation><mixed-citation xml:lang="en">Конь И.Я., Тоболева М.А., Димитриева С.А. Дефицит витаминов у детей: основные причины, формы и пути профилактики у детей раннего и дошкольного возраста // Вопр. современной педиатрии. — 2002. — Т. 1. — № 2. — С. 62–66.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ярош А.К. Сравнительная фармакокинетика препаратов витамина В&lt;sub&gt;1&lt;/sub&gt; (тиамина) и их фармакодинамическая (лечебная) эффективность // Ліки України: Науковий журнал. — 2009. — № 7(133). — С. 71–76.</mixed-citation><mixed-citation xml:lang="en">Ярош А.К. Сравнительная фармакокинетика препаратов витамина В&lt;sub&gt;1&lt;/sub&gt; (тиамина) и их фармакодинамическая (лечебная) эффективность // Ліки України: Науковий журнал. — 2009. — № 7(133). — С. 71–76.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Volvert M.L., Seyen S., Piette M. et al. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipidsoluble thiamine disulfide derivatives // Posted. — 2008. — Vol. 11. — Р. 19.</mixed-citation><mixed-citation xml:lang="en">Volvert M.L., Seyen S., Piette M. et al. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipidsoluble thiamine disulfide derivatives // Posted. — 2008. — Vol. 11. — Р. 19.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wada T., Takagi H., Minakami H. et al. A new thiamine derivate, S-benzoylthiamine O-monophosphate // Scien. — 1961. — Vol. 134. — P. 195–196.</mixed-citation><mixed-citation xml:lang="en">Wada T., Takagi H., Minakami H. et al. A new thiamine derivate, S-benzoylthiamine O-monophosphate // Scien. — 1961. — Vol. 134. — P. 195–196.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fujiwara M., Watanabe H., Matsui K. Allithiamine a newly found derivate of vitamin B1. I. Discovery of Allithiamine // J. Biochem. — 1954. — Vol. 41. — P. 29–39.</mixed-citation><mixed-citation xml:lang="en">Fujiwara M., Watanabe H., Matsui K. Allithiamine a newly found derivate of vitamin B1. I. Discovery of Allithiamine // J. Biochem. — 1954. — Vol. 41. — P. 29–39.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Baker H., Frank O. Absorption, utilization and clinical effectiveness of allithiamines compared to water-soluble thiamines // J. Nutr. Sc. Vitaminol. — 1976. — Vol. 22. — P. 63–68.</mixed-citation><mixed-citation xml:lang="en">Baker H., Frank O. Absorption, utilization and clinical effectiveness of allithiamines compared to water-soluble thiamines // J. Nutr. Sc. Vitaminol. — 1976. — Vol. 22. — P. 63–68.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Geissler C., Powers H. Human Nutrition. — Edinburgh, 2006. — 763 p.</mixed-citation><mixed-citation xml:lang="en">Geissler C., Powers H. Human Nutrition. — Edinburgh, 2006. — 763 p.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Davis R.E. Clinical chemistry of thiamine // Adv. Clin. Chem. — 1983. — Vol. 23. — P. 93–140.</mixed-citation><mixed-citation xml:lang="en">Davis R.E. Clinical chemistry of thiamine // Adv. Clin. Chem. — 1983. — Vol. 23. — P. 93–140.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
